Peter Zandstra

Last updated

Peter Zandstra
CM FRSC
Born
Peter W. Zandstra
Alma mater McGill University
University of British Columbia (PhD)
Massachusetts Institute of Technology
Awards
Scientific career
Fields
Institutions
Website www.stemcellbioengineering.ca

Peter W. Zandstra, CM FRSC is a Canadian scientist who is the Director of the Michael Smith Laboratories at the University of British Columbia.

Contents

Education

Zandstra graduated with a Bachelor of Engineering degree from McGill University in the Department of Chemical Engineering and later obtained his Ph.D. degree from the University of British Columbia in the Department of Chemical Engineering and Biotechnology, under the supervision of Jamie Piret and Connie Eaves. He continued his research training as a Post Doctoral Fellow in the field of Bioengineering at the Massachusetts Institute of Technology (with Doug Lauffenburger) before being appointed to the University of Toronto in 1999. [1]

Career

In 2007, Zandstra was appointed as a Professor at the University of Toronto's Institute of Biomaterials and Biomedical Engineering. [2] He was cross appointed with the Departments of Chemical Engineering and Applied Chemistry and Medical Genetics. In 2016, Zandstra became a Professor at the University of British Columbia. He served as the Founding Director of the School of Biomedical Engineering at the University of British Columbia [3] and was the Director of the Michael Smith Laboratories until July 2022. [4] In July 2023, he was reappointed to a second term as Director of the School of Biomedical Engineering. [5]

Zandstra also serves on the advisory board of the Phil and Penny Knight Campus for Accelerating Scientific Impact of the University of Oregon [4] and serves as Chief Scientist at the Creative Destruction Lab. [6] He also is a Chief Scientific Officer at the Centre for Commercialization of Regenerative Medicine [7] and is a part of the Silver Creek Pharmaceuticals team. [8]

Research

Research in the Zandstra Laboratory is focused on the regeneration of functional tissues from stem cells, and the development and utilization of tools to modulate the responses of stem cells in vitro and in vivo. Interest in the generation of primary cells and tissues ex vivo is driven both by their potential use as a direct clinical modality and as human tissue analogues for the development of novel therapeutic agents. [1] Zandstra's group is particularly interested in understanding the role that the extracellular environment, the stem cell niche, plays in controlling stem cell fate decisions. Using quantitative bioengineering approaches including micro-fabrication, bioreactors, mathematical modeling, protein engineering and cell engineering, the Zandstra Lab is discovering how stem cells integrate their complex microenvironment to make self-renewal or differentiation divisions. The group is focused on using this understanding to enable new therapeutically and technologically relevant strategies in regenerative medicine. The Zandstra lab focuses in particular on understanding how to grow human blood stem cells, and on understanding how to differentiate pluripotent stem cells into functional blood, cardiac, and pancreatic tissue.

Zandstra currently serves as associate editor for the journals Stem Cells , Stem Cell Research and Biotechnology and Bioengineering .

In addition to his research, Zandstra teaches in Cellular Engineering, having developed both undergraduate and graduate curricula covering the use of mathematical models to describe and predict cell fate decisions. Zandstra helped with the founding of the IBBME teaching laboratory, designing and implementing more than 6 labs. He currently serves as the Director of the University of Toronto's Minor in Bioengineering, an engineering faculty-wide program designed to give undergraduate students a co-ordained series of courses in bioengineering related topics.

Awards and honours

In 2008, during an annual conference held by the American Association for the Advancement of Science, Zandstra was inducted as its Fellow. [9]

In 2014, Zandstra was elected as a Fellow of the Royal Society of Canada [10] and a year later he was recognized for contributions to development and commercialization of stem cell-based therapies and became a recipient of the Scale-Up and Manufacturing of Cell-Based Therapies Award. [11]

In 2017, Zandstra was appointed as Canada Research Chair in Stem Cell Bioengineering. [12]

His other recognitions include:

Related Research Articles

Sajeev John, OC, FRSC is a Professor of Physics at the University of Toronto and Canada Research Chair holder. He is known for his discovery of photonic crystals.

<span class="mw-page-title-main">Sangeeta Bhatia</span> American nanotechnologist

Sangeeta N. Bhatia is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.

<span class="mw-page-title-main">Linda Griffith</span> American biological engineer

Linda Gay Griffith is an American biological engineer, and Professor of Biological Engineering and Mechanical Engineering at Massachusetts Institute of Technology, where she also directs the Center for Gynepathology Research.

Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering, an Associate Professor of Surgery, and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels, tissue engineering, and regenerative medicine.

<span class="mw-page-title-main">Gordana Vunjak-Novakovic</span> Serbian American engineer

Gordana Vunjak-NovakovicFRSC is a Serbian American biomedical engineer and university professor. She is a University Professor at Columbia University, as well as the Mikati Foundation Professor of Biomedical Engineering and Medical Sciences. She also heads the laboratory for Stem Cells and Tissue Engineering at Columbia University. She is part of the faculty at the Irving Comprehensive Cancer Center and the Center for Human Development, both found at Columbia University. She is also an honorary professor at the Faculty of Technology and Metallurgy at the University of Belgrade, an honorary professor at the University of Novi Sad, and an adjunct professor at the Department of Biomedical Engineering at Tufts University.

Martin (Maish) L. Yarmush is an academic, American scientist, physician, and engineer known for his work in biotechnology and bioengineering. His faculty career began in 1984 at MIT in the Department of Chemical Engineering as a Principal Research Associate and Lucille P. Markey Scholar in Biomedical Science. In 1988 he joined Rutgers University, as Professor of Chemical and Biochemical Engineering and a member of the Center of Advanced Biotechnology and Medicine. In 1995, he returned to the Boston area to serve as the Helen Andrus Benedict Professor of Surgery and Bioengineering in the Harvard-MIT Division of Health Sciences and Technology, and to establish the Center for Engineering in Medicine at the Harvard Affiliated Teaching Hospitals. In 2007 he returned to Rutgers to hold the Paul and Mary Monroe Endowed Chair in Science and Engineering and serve as Distinguished Professor in the Department of Biomedical Engineering. He also holds a Lecturer in Surgery and Bioengineering position at Harvard Medical School, and is a member of the Senior Scientific Staff at the Shriners children's hospital in Boston.

<span class="mw-page-title-main">George Truskey</span>

George Alexander Truskey is an American biomedical engineer noted for his research on transport phenomena in biological systems, cardiovascular tissue engineering, and cell adhesion to natural and synthetic surfaces.

Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.

<span class="mw-page-title-main">Eugenia Kumacheva</span> Canadian chemist

Eugenia Eduardovna Kumacheva is a University Professor and Distinguished Professor of Chemistry at the University of Toronto. Her research interests span across the fields of fundamental and applied polymers science, nanotechnology, microfluidics, and interface chemistry. She was awarded the L'Oréal-UNESCO Awards for Women in Science in 2008 "for the design and development of new materials with many applications including targeted drug delivery for cancer treatments and materials for high density optical data storage". In 2011, she published a book on the Microfluidic Reactors for Polymer Particles co-authored with Piotr Garstecki. She is Canadian Research Chair in Advanced Polymer Materials. She is Fellow of the Royal Society (FRS) and a Fellow of the Royal Society of Canada (FRSC).

Treena Livingston Arinzeh is an American biomedical engineer and academic.

<span class="mw-page-title-main">Antonios Mikos</span> Greek-American biomedical engineer

Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials, drug delivery, and tissue engineering.

<span class="mw-page-title-main">Jennifer Elisseeff</span> Professor of biomedical engineering

Jennifer Hartt Elisseeff is an American biomedical engineer, ophthalmologist and academic. She is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in Chemical Engineering, Biomedical Engineering, Materials Science and Orthopedic Surgery. Elisseeff's research is in the fields of regenerative medicine and immunoengineering.

<span class="mw-page-title-main">Akhilesh K. Gaharwar</span> Indian biomedical engineering researcher (born 1982)

Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.

Laura Elizabeth Niklason is a physician, professor and internationally recognized researcher in vascular and lung tissue engineering. She is the Nicholas M. Greene Professor of Anesthesiology and Biomedical Engineering at Yale University and co-founder, chief executive officer and president of Humacyte, a regenerative medicine company developing bioengineered human tissues.

Craig Alexander Simmons is a Canadian mechanobiologist and professor at the University of Toronto. He received a master's degree in mechanical engineering from Massachusetts Institute of Technology and a Ph.D. in mechanical engineering from the University of Toronto. Simmons contributes to the fields of mechanobiology, stem cells, microfluidics and tissue engineering.

<span class="mw-page-title-main">Milica Radisic</span> Serbian Canadian tissue engineer

Milica Radisic is a Serbian Canadian tissue engineer, academic and researcher. She is a professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering, and the Department of Chemical Engineering and Applied Chemistry. She co-founded TARA Biosystems and is a senior scientist at the Toronto General Hospital Research Institute.

Shelly R. Peyton is an American chemical engineer who is the Armstrong Professional Development Professor in the Department of CHemical Engineering at the University of Massachusetts Amherst. Her research considers the development of biomaterials to investigate metastatic cancer and potential new therapies.

Helen Haiyan Lu is a Chinese American biomedical engineer and the Percy K. and Vida L. W. Hudson professor of biomedical engineering at the Columbia University Fu Foundation School of Engineering and Applied Science. Her work focuses on understanding and developing therapies in complex tissue systems, especially the interface between soft tissue and bone.

Farshid Guilak is an American engineer and orthopedic researcher. He is the Mildred B. Simon Professor of Orthopaedic Surgery at Washington University in St. Louis and director of research at Shriners Hospitals for Children. He is also on the faculty of the departments of Biomedical Engineering, Mechanical Engineering & Materials Science, and Developmental Biology at Washington University.

Aaron R. Wheeler is a Canadian chemist who is a professor of chemistry and biomedical engineering at the University of Toronto since 2005 with cross-appointment at Institute of Biomedical Engineering and Terrence Donnelly Centre for Cellular and Biomolecular Research. His academic laboratory is located at Lash Miller Chemical Laboratories and Terrence Donnelly Centre for Cellular and Biomolecular Research at the University of Toronto. In 2005, Wheeler was appointed as assistant professor and Tier II Canada Research Chair then promoted to associate professor in 2010, full professor in 2013, and in 2018 he became the Tier I Canada Research Chair in Microfluidic Bioanalysis.

References

  1. 1 2 "Peter Zandstra Ph.D., P.Eng., FRSC". Stem Cell Bioengineering. Retrieved August 17, 2019.
  2. ↑ "Peter Zandstra named University Professor, U of T's highest academic rank". University of Toronto. June 3, 2016. Retrieved August 17, 2019.
  3. ↑ "Peter Zandstra joins UBC to lead the newly established School of Biomedical Engineering". University of British Columbia. July 1, 2017. Retrieved August 17, 2019.
  4. 1 2 "Peter Zandstra". August 2, 2018. Retrieved August 17, 2019.
  5. ↑ "Dr. Peter Zandstra reappointed Director, School of Biomedical Engineering". July 19, 2023.
  6. ↑ "Peter Zandstra". Creative Destruction Lab. Retrieved August 17, 2019.
  7. ↑ "Peter Zandstra". Centre for Commercialization of Regenerative Medicine. Retrieved August 17, 2019.
  8. ↑ "Peter Zandstra". Silver Creek Pharmaceuticals. Retrieved August 17, 2019.
  9. ↑ "From stem cells to organs: The bioengineering challenge". Phys.org . February 16, 2008. Retrieved August 17, 2019.
  10. ↑ "Ted Sargent and Peter Zandstra named Fellows of the Royal Society of Canada". University of Toronto. September 11, 2014. Retrieved August 17, 2019.
  11. ↑ Luke Ng (October 3, 2016). "Peter Zandstra recognized for contributions to development and commercialization of stem cell-based therapies". University of Toronto. Retrieved August 17, 2019.
  12. ↑ "Peter Zandstra". November 29, 2012. Retrieved August 17, 2019.
  13. ↑ "Past Winner of the 2005 E.W.R. Steacie Memorial Fellowship: Peter Zandstra". Natural Sciences and Engineering Research Council of Canada. February 27, 2013. Retrieved August 17, 2019.
  14. ↑ "Peter Zandstra". Guggenheim Fellowship. Retrieved August 17, 2019.
  15. ↑ "McLean Award: Past Winners" (PDF). University of Toronto. Retrieved August 17, 2019.
  16. ↑ "Peter Zandstra, Ph.D." AIMBE . Retrieved August 17, 2019.
  17. ↑ "Till & McCulloch Award Goes to IBBME's Peter Zandstra". University of Toronto. September 26, 2013. Retrieved August 17, 2019.
  18. ↑ "Professor Peter Zandstra, PhD, FRSC, PEng". American Institute of Chemical Engineers. February 29, 2012. Retrieved August 17, 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.